In Ph+ALL, the oncogenic fusion BCR-ABL stimulates some pre-BCR downstream effectors, such as Bruton’s tyrosine kinase (BTK), the transcription regulator protein BACH2 and B Cell CLL/Lymphoma 6 (BCL6) [138,170]. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.